Specifications Manual for Joint Commission National Quality Core Measures (2010B)

Release Notes:
References Stroke
Version 2010B

References

Adams HP, Adams R, del Zoppo G, Goldstein LB. Guidelines for the early management of patients with ischemic stroke: Guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke. 2005;36:916-923.

Adams HP, Adams RJ, et al. Guidelines for the early management of patients with ischemic stroke. Stroke. 2003;34:1056-1083.

Adams HP, Brott T, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1994;90:1588-1601.

Adams HP, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute stroke. Circulation. 1996; 94:1167-1174.

Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EFM. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke. 2007;38:1655-1711.

AHA Scientific Statement - Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association Larry B. Goldstein, MD, Chair; Robert Adams, MD; Kyra Becker, MD; Curt D. Furberg, MD; Philip B. Gorelick, MD; George Hademenos, PhD; Martha Hill, PhD, RN; George Howard, PhD; Virginia J. Howard, MSPH; Bradley Jacobs, MD; Steven R. Levine, MD; Lori Mosca, MD; Ralph L. Sacco, MD; David G. Sherman, MD; Philip A. Wolf, MD; Gregory J. del Zoppo, MD; Members – January 2001.

Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST. 2004;126:483S–512S.

Albers GW, et al. Antithrombotic: Thrombolytic therapy for ischemic stroke. The Sixth ACCP Consensus Conference on Antithrombotic Therapy. CHEST. 2001; 119:3005-3205.

Albers GW, Easton D, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. CHEST. 2001;119:301S-320S.

Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, and Singer DE. Antithrombotic therapy in atrial fibrillation. CHEST. 2001;119:194S-206S. Retrieved August 2, 2007 from World Wide Web: http://chestjournal.org/cgi/content/full/119/1_suppl/194S.

Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, Koroshetz W, Marler JR, Booss J, Zorowitz RD, Croft JB, Magnis E, Mulligan D, Jagoda A, OConnor R, Cawley CM, Connors JJ, Rose-DeRenzy JA, Emr M, Warren M, Walker MD. Recommendations for Comprehensive Stroke Centers: A consensus statement from the Brain Attack Coalition. Stroke published online Jun 16, 2005. Retrieved August 2, 2007 from World Wide Web: http://stroke.ahajournals.org.

Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. Journal of Neurology, Neurosurgery & Psychiatry. 1996;60:197-199.

Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. Journal of Neurology, Neurosurgery & Psychiatry. 1996;66:255-255.

American Academy of Physical Medicine and Rehabilitation. Rehabilitation Helps Stroke Patients Recover Skills. AAPM&R Chicago, IL Office: Author. Retrieved July 7, 2004 from World Wide Web: http://www.aapmr.org’condtreat/rehab/recover.htm.

American Academy of Physical Medicine and Rehabilitation. Rehabilitation Helps Stroke Patients Recover Skills Therapy, Helps in Regaining Coordination, Full Speech, and Other Abilities. AAPM&R Chicago, IL Office: Author. Retrieved July 7, 2004 from World Wide Web: http://www.aapmr.org’condtreat/rehab/recover.htm.

American Academy of Physical Medicine and Rehabilitation. Urgency Key But Perserverance Pays Off. AAPM&R Chicago, IL Office: Author. Retrieved July 7, 2004 from World Wide Web: http://www.aapmr.org’condtreat/rehab/recover.htm.

American College of Emergency Physicians. ACEP Policy Statement: Use of tPA for the management of acute stroke in the emergency department. Dallas, TX: Author, 2002.

American Diabetes Association - Professional Association. Aspirin therapy in diabetes. Diabetes Care. 1999;22(1):1-4.

American Heart Association Task Force on Risk Reduction. Guide to primary prevention of CV diseases. Circulation. 1997;95:2329-2331.

American Heart Association Task Force on Risk Reduction. Primary prevention of coronary heart disease: Guidance from Framingham. Professional Statement. Circulation. 1998;97:1876-1887.

American Heart Association. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Council of the American Heart Association. Stroke. 1999;30:1991-1994.

American Heart Association. Acute stroke care in the US: Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. The Paul Coverdell Prototype Registry Writing Group. Stroke. 2005;36: 1232-1240.

Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.

ASA Scientific Statement -Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: A statement for healthcare professionals from the Stroke Council of the American Heart Association, Philip A. Wolf, MD, Chair; G. Pat Clagett, MD; J. Donald Easton, MD; Larry B. Goldstein, MD; Philip B. Gorelick, MD; Margaret Kelly-Hayes, EdD? , RN; Ralph L. Sacco, MD; Jack P. Whisnant, MD – September 1999.

Barnett HJM, Eliasziw M, Meldrum HE. Drug therapy: Drugs and surgery in the prevention of ischemic stroke. NEJM. 1995;332:238-248.

Barnett HJM, Eliaziw M, Meldrum HE. Evidence-based cardiology: Prevention of ischaemic stroke. BMJ. 1999;318:1539.

Benavente O, Hart RG. Stroke: Part II. Management of acute ischemic stroke. American Family Physician. 1999.

Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465-8.

Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy: A statement of healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 1998;29:554-562.

Biller, J, et al. Guidelines for carotid endarterectomy: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1998;97(5):501-9.

Bousser MG, Eschwege E, Haguenau M, et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983;14:5-14.

Broderick J, Connolly, Feldmann E, Hanley D, Kase, C, Kriegerr D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, and Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: A guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007;38;2001-2023.

Brott TG, Clark WM, Grotta JC, et al. Stroke the first hours. Guidelines for acute treatment. Consensus Statement. National Stoke Association. 2000.

Caplan LR, Mohr JP, Kistler JP, Koroshetz W, Grotta J. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? NEJM. 1997;337:1309-1313.

CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.

Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31:1240-1249.

Clagett GP, Anderson FA, Geerts W, et al. Prevention of venous thromboembolism. CHEST. 1998;114:531S-560S.

Clinical Efficacy Assessment Subcommittee HaPPC. Guidelines for medical treatment for stroke prevention. American College of Physicians. Ann Intern Med. 1994;121:54-55.

Coull BM, Williams LS, Goldstein LB, et al. Aticoagulants and antiplatelet agents in acute ischemic stroke. Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Stroke. 2002;33:1934 -1942.

Counsell C, Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review). The Cochrane Library. 1999;1-13.

Desmukh M, Bisignami M, Landau P, Orchard TJ. Deep vein thrombosis in rehabilitating stroke patients: Incidence, risk factors and prophylaxis. American Journal Physical Medicine Rehabilitation. 1991; 70:313-316.

Diagnosis and Treatment of Swallowing Disorders (Dysphagia) in Acure-Care Stroke Patients. Summary, Evidence Report/Technology Assessment: Number 8, March 1999. Agency for Health Care Policy and Research, Rockville, MD. http://www.arhq.gov/clinic/epcsums/dysphsum.htm.

Diener HCCL, Forbes CD, Sivenius J, Smets J, Lowenthal A. European stroke prevention study. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of the Neurological Sciences. 1996;143:1-13.

Doggett DL, Tappe KA et al. Prevention of pneumonia in elderly stroke patients by systemic diagnosis and treatment of dysphagia: An evidence-based comprehensive analysis of the literature. Dysphagia. 2001;16:279-295.

EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.

Duncan, et al. Stroke rehabilitation clinical practice guidelines. Stroke. 2005; 36:e100-e143.

Ebrahim, S. Clinical Epidemiology of Stroke. Oxford, Oxford University Press; 1990:177-178.

Eccles M, Freemantle N, Mason J, North of England Aspirin Guideline Development Group. Education and debate: North of England evidence based guideline development project: Guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ. 1998;316:1303-1309.

ECRI Investigators. Diagnosis and treatment of swallowing disorders (dysphagia) in acute-care stroke. Agency for Health Care Policy and Research. Evidence Report/Technology Assessment: Number 8. 1999.

Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC; GAIN Americas Investigators. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology. 2007 Mar 13;68(11)842-8.

Evans RL, Matlock AL, Bishop DS, Stranahan S, Pederson C. Family intervention after stroke: Does counseling or education help? Stroke. 1988;19:1243-1249.

Excerpt taken from Holloway RG, Benesch CG, Vickrey BG, and Hinchey JA. Stroke Quality of Care Study: Draft quality indicators and literature review. University of Rochester, Rochester NY, 1999. [Literature Monograph] Fagan SC, Morgenstern LB, Petitta A, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology. 1998;50:883-890.

Farrell B, Godwin J, Richards S, Warlow CP. The United Kingdom Transient Ischaemic Attack (UK-TIA) Aspirin Trial: Final results. Journal of Neurology, Neurosurgery & Psychiatry. 1991;54:1044-1054.

Feinberg WM, Albers GW, Barnett HJM, et al. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. 1994.

Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation – executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006. Retrieved August 2, 2007 from World Wide Web: http://www.circ.ahajournals.org.

Fuster et al., ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation. JACC. August 2001;38:1231-6.

Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. CHEST. Sep 2004;126(3 Suppl):338S-400S.

Gent M, Blakely JA, Easton JD. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet. 1989;1:1215-1220.

Goldstein LB, Hey LA, Laney R. North Carolina stroke prevention and treatment facilities survey. Statewide availability of programs and services. Stroke. 2000;31:66-70.

Goldstein LB, Adams R, Albert MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:1583.

Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander l, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 1999;281:1112-1120.

Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2000;2.

Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke (Cochrane Review). The Cochrane Library, Issue 3, 1999. Oxford: Update Software, 1-23.

Guideline on the Use of Aspirin as Secondary Prophylaxis for Vascular Disease in Primary Care, Centre for Health Services Research University of Newcastle upon Tyne, & Centre for Health Economics of York, 1998.

Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.

Harper G. Treatment of stroke in older patients. A state of the art review. Drugs & Aging. 1995;6:29-44.

Hass WK, Easton JD, Adams HPJ, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study (TASS) Group. NEJM. 1989; 321:501-507.

Helgason CM, Wolf PA. American Heart Association Prevention Conference IV: Prevention and rehabilitation of stroke: Executive summary. Circulation. 1997;96:701-707.

Hennekens CH, Dyken ML, Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1997;96:2751-2753.

Hirsh J, Dalen JE, and Guyatt G. The Sixth (2000) ACCP Guidlelines for Antithrombotic Therapy for Prevention and Treatment of Thrombosis. CHEST. 2001;119:1S-2S.

Hirsh J, Fuster V. Guide to anticoagulant therapy Part 1: Heparin. Circulation. 1994;89:1449-1468.

Holloway RG, Benesch CG, Vickrey BG, and Hinchey JA. Stroke Quality of Care Study: Draft Quality Indicators and Literature Review. University of Rochester, Rochester NY, 1999. [Literature Monograph] Institute for Clinical Systems Improvement (ICSI). Diagnosis and initial treatment of ischemic stroke. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2003 Oct. 65 p. [113 references]

International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither amoung 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.

Ischemic Stroke. Stroke. 2003;34:1056-1083.

Kaiser Permanente Clinical Practice Guidelines for Acute Stroke Quartet III Inpatient Management, 1998.

Kresowik TF, Nilasena DS, et al. Deep Vein Thrombosis Prophylaxis in Medicare Patients with Ischemic Stroke: Results from the National Stroke Project. Oral Abstract Presentation 26th International Stroke Conference. 2001.

Lindsay MP, Kapral MK, Silver FL, Hill M, Gladstone DJ, Jaigobin C, Bayley M, Tu JV, Laupacis A. Canadian Stroke Quality of Care Study: Consensus-Based Performance Measures Across the Continuum of Stroke Care Master List. Canadian Stroke Network, Ottawa Ontario. April 2006.

Liu M, Counsell C, Sandercock P. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack (Cochrane Review). The Cochrane Library, Issue 3, 1999. Oxford: Update Software, 1-18.

Loewen P, Sunderji R, Gin K. The efficacy and safety of combination warfarin and ASA therapy: A systematic review of the literature and update of guidelines. Canadian Journal of Cardiology. 1998;14:717-726. Loring KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial. Medical Care. 1999; 37:5-14. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Broderick JP, Levine SR, Frankel MP, Horowitz SH, Haley EC, Lewandowski CA, Kwiatkowski TP. Early stroke treatment associated with better outcome The NINDS rt-PA Stroke Study. Neurology. 2000;55:1649-1655.

McCarthy ST, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. Age & Aging. 1986;15:84-88.

McCarthy ST, Turner JJ, Robertson D. Low dose heparin as a prophylaxis against deep vein thrombosis after acute stroke. Lancet. 1977;2:800-801.

Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio R, Barrett-Connor E. Cardiovascular disease in women. Circulation. 1997;96:2468-2482.

National Institute of Neurological Disorders and Stroke. National Institute of Neurological Disorders and Stroke, Proceedings of a National Symposium of Rapid Identification and Treatment of Acute Stroke. Marler, J. R., Winters-Jones, P., and EMR, M. NIH Publication No. 97-4239. 1997. Bethesda, MD, National Institutes of Health.

National Institute of Neurological Disorders. Post-Stroke Rehabilitation Fact Sheet. National Institute of Neurological Disorders Bethesda, MD Office: Author. Retrieved July 7, 2004 from World Wide Web: http://www.ninds.nih.gov/health_and_medical/pubs/poststrokerehab.htm.

National Institutes of Health. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. National Cholesterol Education Program National Heart, Ling, and Blood Institute National Institutes of Health. NIH Publication No. 12-5215. 2002.

National Stroke Association (NSA). STROKE the first hours Guideline for Acute Treatment. Englewood, CO: National Stroke Association (NSA); 2000.

Norris J, Buchan AM, Cote R, et al. Canadian guidelines for intravenous thrombolytic treatment with acute stroke. Can J Neurol Sci. 1998;25:257-259.

Ockene IS, Miller NH. Cigarette Smoking, Cardiovascular Disease and Stroke. Circulation. 1997;96:3243-3247.

Odderson IR, Keaton JC, et al. Swallow management in patients on an acute stroke pathway: Quality is cost effective. Arch Phys Med Rehabil. 1995;76:1130-1133.

Plehn Y F, Davis BR, Sacks FM, et al. Reduction of stroke incidence after myocardial infarction with pravastatin the cholesterol and recurrent events (CARE) study. Circulation. 1999; 99: 216-223.

Preventive Services Task Force. Smoking Cessation. In: Guide to Clinical Prevention Services. AHCPR Publication No. 96-0692 ed. Baltimore, MD: Williams and Wilkins, 1996:432-446.

Prins MH, den Ottolander GJH, Gelsema R, et al. Deep vein thrombosis prophylaxis with a low molecular weight heparin (Kabi 2165) in stroke patients. Thromb Haemost. 1987;58:117.

Pushpangadan M, Wright J, Young J. Evidence-based guidelines for early stroke management. Hospital Medicine. 1999;60:105-114.

Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice Advisory: Thrombolytic therapy for acute ischemic stroke - summary statement. Neurology. 1996;47:835-839.

Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention. Stroke. 2006;37:577.

Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Seminars in Thrombosis & Hemostasis. 1990;16 Supplement:25-33.

Schooley, Y. Recommendations for the Nursing Management of the Hyperacute Ischemic Stroke Patient. Shepard, TJ. 1-20. 98. American Association of Neuroscience Nurses. Clinical Guidelines Series.

Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Assessment, investigation, immediate management and secondary prevention. Scottish Intercollegiate Guidelines Network, 1997.

Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Identification and management of dysphagia. Scottish Intercollegiate Guidelines Network, 1997.

Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Rehabilitation, prevention and management of complications and discharge planning. Scottish Intercollegiate Guidelines Network, 2002.

Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789-794.

Smith, PEM. Smoking and stroke: A causative role. (Editorial) BR Med J. 1998; 317: 962-3.

Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. NEJM. 2006;355:459-559.

Stroke Prevention: Recommendations. Research findings for clinicians. AHCPR Publication No. 95-0091,1-3. 1999.

Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomized trials of organized inpatient (stroke unit) care after stroke. BMJ. 1997;314:1151-1159.

The ATLANTIS, ECASS, and NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke Trials. Lancet. 2004;363:768-774.

The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. NEJM. 1991;325:1261-1266.

The European Ad Hoc Consensus Group. European strategies for early intervention in stroke. Cerebrovasc Dis. 1996;6:315-324.

The European Ad Hoc Consensus Group. Optimizing intensive care in stroke: A European perspective. Cerebrovasc Dis.1997;7:113-128.

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. NEJM. 1995;333:1581-1587.

The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.

Turpie AG, Gent M, Cote R, et al. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study. Ann Intern Med. 1992;117:353-357.

Turpie AG, Levine MN, Powers PJ, et al. A double-blind randomized trial of ORG 10172 low molecular weight heparinoid versus unfractionated heparin in the prevention of deep vein thrombosis in patients with thrombotic stroke. Thromb Haemost. 1991;65:753.

US Department of Health and Human Services. Post-stroke rehabilitation: Assessment, referral, and patient management. In: Agency for Health Care Policy and Research, ed. Quick Reference Guide for Clinicians Number 16. AHCPR Publication No. 95-0062 ed. Rockville, MD: Public Health Service, 1995.

U.S. Department of Health and Human Services. Agency for Health Care Policy and Research. Smoking cessation, Clinical Practice Guideline No. 18. ACHPR Publication No. 96-0692. Rockville, MD: Public Health Service, 1996.

Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Stroke Rehabilitation in the Primary Care Setting. Department of Veteran Affairs Department of Defense, 2003.

Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care. Stroke. 2005;36:2049. Retrieved August 2, 2007 from World Wide Web: http://stroke.ahajournals.org/cgi/content/full/36/9/2049.

Vanek V. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh high to knee high sleeves. American Surgeon. 1998;64:1050-1058.

Wardlaw J, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997;350:607-614.

Wardlaw J, Yamaguchi T, del Zoppo G. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library, Issue 3, 1999. Oxford: Update Software, 1-19.

Wattigney WA, Croft JB, Mensah GA, Alberts MJ, Shephard TJ, Gorelick PB, et al. Establishing data elements for the Paul Coverdell National Acute Stroke Registry – Part 1: Proceedings of an expert panel. Stroke. 2003;34: 151-156.

Wolf P, Kannel W, Bonita R, Belanger A. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA. 1988;259:1025-1029.

Wolf PA, Clagett GP, Easton D, Goldstein LB, Gorelick PB, Kelly-Hayes M, Sacco RL, Whisnant JP. AHA Scientific Statement Preventing Ischemic Stroke in Patients With Prior Stroke and Transient Ischemic Attack. Stroke 1999;30:1991-1994.

Xie J, George MG, Ayala C, McGruder HF, Denny CH, Croft JB. Outpatient Rehabilitation Among Stroke Survivors---21 States and the District of Columbia, 2005. CDC MMWR. May 25, 2007 / 56(20);504-507. Retrieved August 2, 2007 from World Wide Web: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5620a4.htm?s_cid=mm5620a4_e.

Zorowitz RD, et al. The Post-Stroke Rehabilitation Outcomes Project (PSROP), Top Stroke Rehabil. 2005 Fall;12(4).

References

Related Topics